Viral scandals have hit two actresses, a Harvard graduate and a doctor from a top Beijing hospital in recent months.

The US Centers for Disease Control and Prevention (CDC) and Food and Drug Administration (FDA) have launched investigations ...

GSK today announced that the US Food and Drug Administration (FDA) has approved a prefilled syringe formulation of its ...

Abbott Laboratories(NYSE:ABT) reported its second-quarter 2025 results on July 17, 2025, posting 7.5% organic sales growth (excluding COVID testing), 12% medical device growth, and adjusted EPS of $1.

The Iowa Republican spoke in support of the bill passed early Thursday making cuts to foreign aid and public broadcasting.

Centre for Health Protection says Covid activity has declined in city, while doctors warn move may place burden on public ...

Global growth faces headwinds due to continued high uncertainty and tariff impacts. There has been a decoupling in equities, ...

Discover Abbott Laboratories' Q2 2025 highlights: resilience drives high single-digit growth, double-digit EPS, and pipeline innovations.

Medical Devices achieved strong double-digit growth, while the Diagnostics segment in China saw ongoing pressure. These 10 stocks could mint the next wave of millionaires › Abbott Laboratories ...

Abbott warned on Thursday it expects more than $1 billion in financial headwinds this year from a sharp decline in COVID-19 testing demand, new U.S. tariffs, and the government's foreign aid freeze.

Washington could push Beijing to buy more American goods – but deeper issues likely to go unaddressed, ex-Trump ...

Escalating global debt has again raised sharp concerns at a meeting of G20 Finance Ministers and Central Bank Governors, ...